News
Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced a strategic follow-on investment of ...
Psyence Biomedical (NASDAQ: PBM) invested an additional $500,000 in PsyLabs, deepening its relationship with the psychedelic ingredients producer while securing exclusive access to ...
"People may call just to simply process their experience," said project founder Josh White, who microdoses the plant iboga and LSD to "continue to deepen the insight about my life" that he gained ...
“People may call just to simply process their experience,” said project founder Josh White, who microdoses the plant iboga and LSD to “continue to deepen the insight about my life” that he ...
Dave Hannigan: Life in the fast lane of elite sport sport no protection against mental health issues
There, he accessed Ibogaine, a psychoactive compound derived from the iboga plant in Central Africa that is not yet legal in the United States. Between the psychedelics and therapy, he has found ...
COLUMBUS, Ohio, April 16, 2025 /PRNewswire-PRWeb/ -- The Ohio State University's Center for Psychedelic Drug Research and Education (CPDRE) has launched the Global Ibogaine Patient Survey, the ...
derived from the bark of the Gabonian iboga tree. Taken sequentially, the protocol, which is still unapproved for use in the U.S., has shown extraordinary promise in treating veterans in psychic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results